|
|
News Breaks | | | | July 16, 2012 | | 08:02 EDT |  | PRX | Par Pharmaceutical agrees to be acquired by TPG
Par Pharmaceutical announced that it has entered into a definitive merger agreement to be acquired by an affiliate of TPG in a transaction with an equity value of $1.9B. Under the terms of the agreement, Par shareholders will receive $50 in cash for each share of Par common stock, representing a premium of approximately 37% over the closing share price on July 13, 2012, the last full trading day before today's announcement. The agreement was unanimously approved by Par's board. The closing of the transaction is conditioned upon, among other things, the affirmative vote of the holders of a majority of Par's outstanding shares, clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and other customary closing conditions. The transaction is not subject to a financing condition. Under the terms of the merger agreement, Par may solicit superior proposals from third parties through August 24. | |
|
News For PRX From The Last 14 Days Check below for free stories on PRX the last two weeks. |
|
|
| May 22, 2013 | | 09:01 EDT | | PRX | Par Pharmaceutical begins shipment of generic Atacand
 Subscribe for More Information | |
|
|
|
|
|
|
